I am pleased and proud to have been asked to be an expert judge at the LSX meeting in Boston on June 22nd. What an honor!
There is something for everyone at this meeting: medtech, biotech, healthtech. The goal of LSX is to connect senior life science and healthcare executives with investors that have access to capital, and the intelligence, innovation, and partners needed to grow their businesses. LSX accomplishes this with a program that shares the expertise of senior leaders and industry stakeholders.
Great partnering, great topics, fabulous networking. I hope to see you there!
If you have medtech AI technology, we have go to market strategies.
CONTACT US
LOOKING FOR A PARTNER WITH KEY INSIGHTS GO TO MARKET STRATEGIES FOR MEDTECH AI TECHNOLOGY?
OUR LAST THREE PROJECTS WERE:
What price premium can be charged for an upgraded legacy product in a commodity space?
Medtech price sensitivity analysis - hospital administrators and CFOs
M&A due diligence analysis: pricing for a new disruptive product